Logos Global Management LP: holdings and changes

Number 15 of the top 100 funds by copy return. Logos Global Management LP reported 59 US stocks worth $1.7B for the quarter ending 2026-09-30 and changed 16 new, 10 added, 22 trimmed and 25 sold since 2026-06-30.

Copy return, 4 quarters+71.9%
US 500, same time+14.5%
Size$1.7B
Stocks59

Holdings

StockChangeWeightValueShares
PRAX
Praxis Precision Medicines I
ADD +63%7.48%$124M425,000
RVMD
Revolution Medicines INC
TRIM -14%7.44%$123M600,000
IDYA
Ideaya Biosciences INC
TRIM -5%6.62%$110M2,850,000
ERAS
Erasca INC Com
TRIM -51%5.23%$86M5,900,000
ABVX
Abivax Sa-Adr
TRIM -15%5.21%$86M870,000
CGON
Cg Oncology INC
4.18%$69M975,000
IRON
Disc Medicine INC
ADD +16%4.02%$66M1,015,000
BNTX
Biontech Se
TRIM -36%3.86%$64M650,000
TNGX
Tango Therapeutics INC
TRIM -25%3.24%$54M2,150,000
MDGL
Madrigal Pharmaceuticals INC
BUY3.05%$50M100,000
ELVN
Enliven Therapeutics INC
ADD +132%2.99%$50M1,080,000
DYN
Dyne Therapeutics INC
ADD +18%2.92%$48M3,000,000
OCUL
Ocular Therapeutix INC
ADD +13%2.78%$46M6,000,000
DNTH
Dianthus Therapeutics INC
TRIM -38%2.66%$44M500,000
AVBP
Arrivent Biopharma INC
ADD +35%2.47%$41M1,350,000
COGT
Cogent Biosciences INC
ADD +39%2.42%$40M1,250,000
NBIX
Neurocrine Biosciences INC
BUY2.14%$36M250,000
BLTE
Belite Bio INC
TRIM -20%2.05%$34M200,000
AXSM
Axsome Therapeutics INC
BUY1.95%$32M175,000
GPCR
Structure Therapeutics INC
ADD +100%1.89%$31M1,000,000
OLEMA PHARMACE
Olema Pharmaceut
1.68%$28M3,208,875
QUIT
Achieve Life Sciences INC
TRIM -41%1.56%$26M3,200,000
MAZE
Maze Therapeutics
TRIM -52%1.54%$25M935,000
PBLS
Parabilis Medicines, INC.
ADD +43%1.46%$24M750,000
APMD
Apnimed INC
BUY1.46%$24M1,100,000
YARW
Yarrow Bioscience INC
BUY1.40%$23M1,026,258
TRVI
Trevi Therapeutics
TRIM -23%1.25%$21M1,445,000
MANE
Veradermics INC
TRIM -6%1.25%$21M170,000
VERA
Vera Therapeutics INC
TRIM -73%1.17%$19M600,000
SRPT
Sarepta Therapeutics INC
BUY1.10%$18M1,000,000
MLTX
Moonlake Immunot
TRIM -44%1.06%$18M1,500,000
IMCR
Immunocore Holdings Limited
TRIM -17%0.92%$15M500,000
BHVN
Biohaven LTD
BUY0.89%$15M1,100,000
CRSP
Crispr Therapeutics Ag
TRIM -17%0.84%$14M250,000
DFTX
Definium Therapeutics INC
ADD +338%0.81%$13M350,000
ENTX
Entera Bio LTD
BUY0.78%$13M4,411,764
DSGN
Design Therapeutics INC
TRIM -67%0.76%$13M1,000,000
CBIO
Crescent Biopharma INC.
TRIM -55%0.75%$12M850,000
ETRA
Electra Therapeutics INC
BUY0.68%$11M1,000,000
NERV
Minerva Neurosciences INC
0.67%$11M3,288,777
LBRX
Lb Pharmaceuticals INC
TRIM -57%0.58%$10M250,000
VKTX
Viking Therapeutics INC
BUY0.39%$6M200,000
EDIT
Editas Medicine INC
0.35%$6M2,222,000
TNXP
Tonix Pharmaceuticals Hldg Co Com New
BUY0.32%$5M550,000
OCUPHIRE PHARM
Ocuphire Pharma INC
BUY0.29%$5M1,000,000
VOGX
Vogenx INC
BUY0.28%$5M205,000
IMVT
Immunovant INC
TRIM -87%0.17%$3M85,000
JBIO
Jade Biosciences INC
TRIM -82%0.17%$3M200,000
OKUR
Onkure Therapeutics INC
0.16%$3M963,855
TCGX
Tcgx Acquisition Corp
BUY0.15%$2M200,000
UNCY
Unicycive Therapeutics INC
0.13%$2M473,563
PTN
Palatin Technologies INC
0.07%$1M129,260
JATT
Jatt II Acquisition Corp
0.07%$1M100,000
JTTT
Jatt III Acquisition Corp
BUY0.07%$1M100,000
RACC
Research Alliance Corp III
0.07%$1M100,000
SEPN
Septerna INC
0.06%$900k23,548
AMAN
Amanat Acquisition Corp
0.03%$500k50,000
LGVN
Longeveron INC
BUY0.03%$500k192,308
GUTS
Fractyl Health INC
TRIM -50%0.02%$300k504,965
CLDX
Celldex Therapeutics INC
SELL0%was $78M0
CMPS
Compass Pathways PLC
SELL0%was $32M0
MLYS
Mineralys Therapeutics INC
SELL0%was $28M0
REPL
Replimune Group INC
SELL0%was $28M0
XENE
Xenon Pharmaceuticals INC
SELL0%was $27M0
AVTX
Avalo Therapeutics INC
SELL0%was $21M0
RCUS
Arcus Biosciences INC
SELL0%was $20M0
SMMT
Summit Therapeutics
SELL0%was $20M0
SENSEI BIOTHER
Sensei Biotherapeutics INC
SELL0%was $18M0
DBVT
Dbv Technologies S A
SELL0%was $15M0
RYTM
Rhythm Pharmaceuticals INC
SELL0%was $14M0
VOR
Vor Biopharma INC
SELL0%was $12M0
SRRK
Scholar Rock Hldg Corp
SELL0%was $11M0
IMMX
Immix Biopharma INC
SELL0%was $10M0
QTTB
Q32 Bio INC.
SELL0%was $10M0
ODTX
Odyssey Therapeutics, INC.
SELL0%was $10M0
ANNX
Annexon INC
SELL0%was $9M0
RLAY
Relay Therapeutics INC
SELL0%was $6M0
ACADIA PHARMAC
Acadia Pharmacutical INC
SELL0%was $6M0
AMLX
Amylyx Pharmaceuticals INC Com
SELL0%was $6M0
CYBIN INC
Cybin INC
SELL0%was $5M0
TENX
Tenax Therapeutics INC
SELL0%was $4M0
QURE
Uniqure Nv
SELL0%was $1M0
ACRS
Aclaris Therapeutics INC
SELL0%was $1M0
LGVN
Longeveron INC
SELL0%was $900k0

Copy return each quarter

HeldFund copyUS 500
2023-09-30 → 2023-12-31+39.6%+11.2%
2023-12-31 → 2024-03-31+6.4%+10.0%
2024-03-31 → 2024-06-30-15.8%+4.0%
2024-06-30 → 2024-09-30+3.9%+5.4%
2024-09-30 → 2024-12-31-8.2%+2.1%
2024-12-31 → 2025-03-31-27.4%-4.6%
2025-03-31 → 2025-06-30+5.3%+10.5%
2025-06-30 → 2025-09-30+28.5%+7.8%
2025-09-30 → 2025-12-31+36.4%+2.4%
2025-12-31 → 2026-03-31+13.1%-4.6%
2026-03-31 → 2026-06-30+26.0%+14.8%
2026-06-30 → 2026-09-30-11.5%+2.1%

The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.

All top 100 funds, live

Other top funds

Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP